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Abstract
Objective: Basal cell adenocarcinoma of a minor salivary gland is extremely rare. The goal of this
report is to increase awareness of this rare disease and to review and discuss the differential
diagnosis and important considerations in treatment.
Study Design: Case report and review of the literature.
Methods: Case report of a basal cell adenocarcinoma of a hard palate minor salivary gland and
review of the literature of basal cell adenocarcinoma.
Results: Basal cell adenocarcinomas are slow-growing tumours that most commonly involve the
parotid gland and very rarely involve minor salivary glands. Although recurrence rates for these
tumours are high, mortality rates are low. Histological diagnosis is important to distinguish this
tumour from adenoid cystic carcinoma given the significant difference in disease prognosis.
Conclusions: Diagnosis of these tumours must be made histologically. Recommended treatment
options include wide local excision with radiotherapy reserved for close surgical margins or for
local recurrence.
Background
Minor salivary gland neoplasms constitute up to approxi-
mately 25% of all salivary gland tumours [1,2]. The inci-
dence of malignancy of these tumours is slightly greater
than half but varies by series. Basal cell adenocarcinoma
(BCAC) is a rare salivary gland malignancy that occurs
most commonly in the parotid gland [3]. In this report we
describe a case of an older woman presenting with basal
cell adenocarcinoma of a hard palate minor salivary
gland.
Case Presentation
A 69 year-old woman presented with a one-year history of
a persistent ulcer on her hard palate and a poorly fitting
upper denture plate. During this period, the patient had
no weight loss, symptoms of nasal obstruction, nasal dis-
charge, or dysesthesias. A midline 2 × 2.5 cm mass was
present on her central hard palate with raised surfaces, an
area of central ulceration, and soft palate extension. No
lymphadenopathy was detected. An axial computed tom-
ography (CT) scan image revealed a 2-cm heterogeneously
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enhancing mass at the nasal septum extending into the
hard palate (Figure 1) and biopsy of the mass indicated
possible carcinoma.
The patient was taken to the operating room for a com-
bined transnasal endoscopic septectomy and a transoral
maxillectomy. Septal incisions were made around the
mass and carried down to the maxillary crest. The mouth
was opened, and a McIvor mouth gag was placed to main-
tain maximal exposure. Wide local excision of the mass
included a portion of the anterior soft palate and the oral
incision was connected to the septal incision to permit en
bloc resection. On gross pathologic examination, the
tumour had a cystic hemorrhagic granular tan brown
appearance and bone invasion (Figure 2). Low power
examination (Figure 3) demonstrated solid to trabecular
nests of tumour cells with scant cytoplasm, vesicular
nuclei and peripheral palisading. At the periphery, a focus
of angiolymphatic invasion was identified (Figure 4). The
final pathology diagnosis was BCAC of a hard palate
minor salivary gland. Neither radiotherapy nor neck dis-
section was pursued. The patient has remained without
recurrence or disease progression for the 12 months since
her operation. Written consent for publication was
obtained from the patient.
Discussion
BCAC typically arise in adults older than 60 years and
have no gender predominance [4]. Patients present with a
slow-growing mass that unlike this case, usually presents
without ulceration [1]. Local pain is present in about 25%
of patients. The 2005 World Health Organization classifi-
cation categorizes BCAC as a low-grade tumour with a
favourable prognosis [5]. These tumours were first recog-
nized in 1978 and account for approximately 1.6% of all
salivary gland neoplasms [3]. The vast majority occur in
the parotid gland (about 90%) [6-8], followed by the sub-
mandibular gland and minor salivary glands [1].
BCAC is believed to arise from pluripotent ductal reserve
cells. Grossly, these tumours appear solid grey-tan and
grow as large as 7 cm in diameter [9]. BCAC has four
major histologic growth patterns: solid, tubulotrabecular,
Axial non-contrast computed tomography scan demonstrat- ing mass at posterior septum with extension into hard palate Figure 1
Axial non-contrast computed tomography scan dem-
onstrating mass at posterior septum with extension 
into hard palate.
Bisected gross pathologic specimen with areas of focal hem- orrhage Figure 2
Bisected gross pathologic specimen with areas of 
focal hemorrhage.
Histologic appearance of solid/trabecular nests of cells, scant  cytoplasm, vesicular nuclei and peripheral palisading Figure 3
Histologic appearance of solid/trabecular nests of 
cells, scant cytoplasm, vesicular nuclei and peripheral 
palisading. Hematoxylin-eosin, magnification ×100.Head & Neck Oncology 2009, 1:41 http://www.headandneckoncology.org/content/1/1/41
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cribriform and membranous. The solid pattern is the most
common and the most likely to present with perineural
invasion, though the prognostic significance of perineural
invasion in BCAC is unknown. The membranous type has
an appearance resembling dermal eccrine cylindromas. A
syndrome of numerous basal cell adenomas, dermal cell
cylindromas, and trichoepitheliomas has been described
called Brooke-Spiegler Syndrome [4,9]. Most cases of
BCAC are believed to develop de novo but as many as
25% of cases may arise from a pre-existing basal cell ade-
noma [10,11].
The major pathologic differential diagnostic considera-
tions for BCAC are basal cell adenoma and adenoid cystic
carcinoma. As its malignant counterpart, BCAC shares
many histologic characteristics with basal cell adenoma
but is distinguished from basal cell adenomas often only
by invasion of local structures or by perineural or angiol-
ymphatic invasion [12]. Distinguishing BCAC from ade-
noid cystic carcinoma is important due to the poorer
prognosis and higher prevalence of the latter disease.
Major distinguishing features of adenoid cystic carcinoma
are the presence of dark hyperchromatic angulated nuclei
which are in contrast with the vesicular nuclei of BCAC.
Additionally BCAC often have prominent peripheral pal-
isading of the outer layer that adenoid cystic carcinomas
lack [9]. Immunostains are of uncertain value in this dif-
ferential.
BCAC of a minor salivary gland is an extremely rare
tumour with 22 reported cases in the literature. In recent
series' of minor salivary gland tumours, BCAC account for
<1% of all minor salivary gland tumours [12-16]. Overall,
minor salivary gland tumours typically are located on the
hard palate [16]; however, in the few available cases of
minor salivary gland BCAC, they arise commonly from
the buccal mucosa (9) in addition to the palate (7), fol-
lowed by lip and tongue [17]. Patients present with a
slow-growing mass in an area of minor salivary gland dis-
tribution. The prognosis of BCAC of a minor salivary
gland appears similar to that of BCAC of other salivary
glands. The treatment of choice is wide local excision.
Since these tumours seldom metastasise to cervical lymph
nodes, routine neck dissection is not recommended. The
mortality rate for this tumour is also low, although
reported local recurrence rates are high. Parashar et al.
[17] noted that of 17 patients with BCAC of minor sali-
vary glands with follow-up between 2 and 14 years, 2
patients died of the disease, both within 4 years. As with
minor salivary gland malignancies in general, postopera-
tive radiation is recommended for close surgical margins
or following surgical excision of recurrent disease.
Conclusions
Basal cell adenocarcinoma (BCAC) is a rare salivary gland
tumour that carries a favourable prognosis. Although
there are few reported cases of BCAC of minor salivary
gland origin, BCAC should remain a diagnostic consider-
ation. Since these tumours typically require only local
excision, they must be distinguished histologically from
adenoid cystic carcinoma, which has a poorer prognosis
and often necessitates a more aggressive clinical approach.
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